MedPath

Cardiac Rehabilitation for Patients Receiving Radiation Therapy for Thoracic Cancers

Not Applicable
Terminated
Conditions
Thoracic Cancer
Breast Cancer
Sarcoma
Lung Cancer
Thymoma
Esophageal Cancer
Hodgkin Lymphoma
Non-hodgkin Lymphoma
Hodgkin Disease
Interventions
Procedure: Home-based cardiac rehabilitation
Registration Number
NCT04072393
Lead Sponsor
Washington University School of Medicine
Brief Summary

Other than optimizing medical management of cardiac risk factors, and reducing radiotherapy (RT) dose to the heart, there currently exist no interventions to mitigate or reverse the adverse cardiac effects of RT. Aerobic exercise has been demonstrated to improve patient quality of life, cardiac outcomes, and cardiorespiratory fitness in patients with cancer receiving cardiotoxic systemic therapies, but the effects of aerobic exercise on patients at high risk for radiation induced heart disease (RIHD) is unknown. In addition, home-based cardiac rehabilitation has not been tested in patients with thoracic cancers.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
24
Inclusion Criteria
  • Pathologically confirmed or radiographically diagnosed non-small cell lung cancer, small cell lung cancer, esophageal cancer, Hodgkin lymphoma, non-Hodgkin lymphoma, sarcoma, thymoma, or left-sided breast cancer.
  • Planning to receive neo-adjuvant, adjuvant, or definitive radiation therapy to the thorax with curative intent.
  • Willing to participate in home-based cardiac rehabilitation program and be monitored remotely via smart phone application
  • Possess a smart phone or tablet capable of supporting teleHeart application
  • Willing and eligible to co-enroll in the Cardiovascular Toxicity in Cancer and Improvement in Recovery (SURVIVE) Registry Study (HRPO# 201801031).
  • At least 18 years of age.
  • ECOG performance status ≤ 2
  • Ability to understand and willingness to sign an IRB approved written informed consent document (or that of legally authorized representative, if applicable).
Read More
Exclusion Criteria
  • Presence of distant metastatic disease (except patients with lymphoma).
  • Life expectancy less than 6 months
  • Patient lives in skilled nursing facility, chronic care facility, nursing home, or palliative care or hospice facility
  • Unable to walk
  • Presence of significant cancer disease burden that would make patient unlikely to tolerate cardiac rehabilitation (CR)
  • Diagnosis of primary cervical esophageal cancer.
  • Presence of unstable angina.
  • Recipient of heart transplant.
  • Patient on cardiac transplant list or has a ventricular assist device
  • Patient's baseline weight > 300 lbs (due to weight limitations of the scale and bioelectrical impedance device)
  • Pregnant and/or breastfeeding. Women of childbearing potential must have a negative pregnancy test within 14 days of study entry.
  • Other medical comorbidities that make the patient unable to participate in the CR program or other assessments involved with this study.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Home-based cardiac rehabilitationHome-based cardiac rehabilitation* The intervention consists of a prescribed course of home-based cardiac rehabilitation: 36 sessions, three times a week, one hour each, over a period of 12 weeks. * Each customized exercise session includes three phases: * a 5- to 10-minute warm-up which consists of stretching, flexibility movements, and aerobic activity which gradually raises the heart rate to the desired level * a conditioning or training phase, which consists of 20 to 45 minutes of continuous or discontinuous aerobic activity * a cool down for 5 to 10 minutes consisting of low-intensity exercise that permits a gradual recovery from the conditioning phase * The patient will complete a brief questionnaire on the teleHeart application after completing each exercise session on how well they tolerated the exercise. The patient's CR team will receive daily updates from the patient's teleHeart application. Based on feedback from the application, the CR team may modify the patient's exercise program going forward.
Primary Outcome Measures
NameTimeMethod
Feasibility of completing home-based CR after definitive radiation therapy in patients with thoracic cancer who have started the CR programThrough completion of cardiac rehabilitation for all patients enrolled (estimated to be 36 months)

Feasibility of completion is defined as 75% of patients who start their first session of cardiac rehabilitation participating in at least 75% of prescribed home-based CR exercise sessions.

Secondary Outcome Measures
NameTimeMethod
Feasibility of home-based cardiac rehabiliation in all enrolled patients after definitive radiation therapy in patients with thoracic cancer.Through completion of cardiac rehabilitation for all patients enrolled (estimated to be 36 months)

Feasibility is defined as 75% of all enrolled patients of cardiac rehabilitation participating in at least 75% of prescribed home-based CR sessions.

Trial Locations

Locations (1)

Washington University School of Medicine

🇺🇸

Saint Louis, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath